Stay updated on Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial page.

Latest updates to the Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a Locations section with state-level site listings (California, Florida, Massachusetts, Missouri, New York, Pennsylvania, Washington) and updated the page revision to v3.3.3; removed the previous per-state location entries and the HHS Vulnerability Disclosure link (reflecting the change from v3.3.2 to v3.3.3).SummaryDifference0.8%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedNo significant changes to the Study Details page for NCT03063632; the content remains the same, with only minor layout differences observed.SummaryDifference0.1%

- Check43 days agoChange DetectedPublication provenance text updated to indicate PubMed automatic filling (may not be about the study) and the revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.2%

- Check50 days agoChange DetectedThe government funding/operating status notice was removed from the page.SummaryDifference0.3%

- Check64 days agoChange DetectedThe page contains minor UI adjustments and wording changes that do not affect the key study details such as objectives or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedMinor UI tweaks and wording adjustments were made, but core study details and the page's purpose remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial page.